HMMR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.402600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.202000E-01
Normal-vs-Stage2
3.741600E-01
Normal-vs-Stage3
7.314800E-01
Normal-vs-Stage4
6.479800E-01
Stage1-vs-Stage2
5.418800E-01
Stage1-vs-Stage3
4.793400E-01
Stage1-vs-Stage4
9.694600E-01
Stage2-vs-Stage3
1.761430E-01
Stage2-vs-Stage4
6.487200E-01
Stage3-vs-Stage4
3.539400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.332200E-01
Normal-vs-AfricanAmerican
7.219000E-01
Normal-vs-Asian
5.557400E-01
Caucasian-vs-AfricanAmerican
4.932600E-01
Caucasian-vs-Asian
5.749800E-01
AfricanAmerican-vs-Asian
7.546000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.381800E-01
Normal-vs-Female
4.512800E-01
Male-vs-Female
8.400000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.900800E-01
Normal-vs-Age(41-60Yrs)
3.229200E-01
Normal-vs-Age(61-80Yrs)
5.084800E-01
Normal-vs-Age(81-100Yrs)
4.299600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.461390E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.908990E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.534800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.838300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.178200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.779400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.062200E-01
Normal-vs-Daily Drinker
5.201600E-01
Normal-vs-Weekly Drinker
5.413600E-01
Normal-vs-Occasional Drinker
4.433800E-01
Normal-vs-Social Drinker
3.335000E-01
Non Drinker-vs-Daily Drinker
6.993600E-01
Non Drinker-vs-Weekly Drinker
7.475200E-01
Non Drinker-vs-Occasional Drinker
8.360800E-01
Non Drinker-vs-Social Drinker
6.406800E-01
Daily Drinker-vs-Weekly Drinker
9.978600E-01
Daily Drinker-vs-Occasional Drinker
8.557400E-01
Daily Drinker-vs-Social Drinker
3.779200E-01
Weekly Drinker-vs-Occasional Drinker
8.740200E-01
Weekly Drinker-vs-Social Drinker
4.426400E-01
Occasional Drinker-vs-Social Drinker
4.780200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.488800E-01
Normal-vs-Grade 2
8.114400E-01
Normal-vs-Grade 3
8.150200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.814400E-04
Grade 1-vs-Grade 3
2.30339999999218E-05
Grade 1-vs-Grade 4
6.488800E-01
Grade 2-vs-Grade 3
7.052500E-02
Grade 2-vs-Grade 4
8.114400E-01
Grade 3-vs-Grade 4
8.150200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.683400E-01
Normal-vs-NonDiabetic
4.103000E-01
Diabetic-vs-NonDiabetic
2.418400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.358020E-01
Normal-vs-NoPancreatitis
4.927800E-01
Pancreatitis-vs-NoPancreatitis
2.687400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.071000E-01
Normal-vs-N1
4.234400E-01
N0-vs-N1
6.739400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.193700E-02
Normal-vs-TP53-NonMutant
5.530200E-01
TP53-Mutant-vs-TP53-NonMutant
2.79960000004742E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
